This is the question everyone asks: can it be fixed? The honest answer — remission, yes, for most; drug-free 'resolution,' for a lucky minority; a permanent cure, not yet. But for the first time, serious science is measuring resolution and even prevention rather than just hoping.
With modern treat-to-target care, getting RA into remission — disease activity so low it's undetectable — is a realistic, mainstream goal that most people can reach. The catch: it's usually remission while on medication. That's still a transformed life — it's just not the same as being cured. Evidence ●●●●●
A minority (roughly 10–20%) achieve sustained drug-free remission — the closest thing to resolution — and when it happens it often lasts years. The best odds go to those treated early and aggressively in the window of opportunity, with a fast, deep response, and (interestingly) seronegative disease. Tapering has to be cautious and biomarker-guided: the RETRO trial showed stopping drugs abruptly relapses about half of people, while gradual tapering does far better. Evidence ●●●●○
The boldest real science: treating high-risk, antibody-positive people before they ever develop arthritis. Trials show it can work — abatacept (APIPPRA) markedly delayed onset, and rituximab delayed it too — though so far these mostly delay rather than permanently prevent (and hydroxychloroquine flatly failed). Still, 'catch it before it starts' has moved from fantasy to something being measured in real trials. Evidence ●●●○○
Time-to-treatment is the biggest lever
The single biggest factor in whether you reach remission is how fast you're treated. Early, aggressive, tightly-controlled treatment gives you the best shot at drug-free remission — which is exactly why 'wait and see' is the costliest mistake in RA.
The RA Guide